Difference between revisions of "Part:BBa K2065003:Experience"
LauraRijns (Talk | contribs) |
Tjvsonsbeek (Talk | contribs) (→Applications of BBa_K2065003) |
||
| Line 3: | Line 3: | ||
==iGEM TU Eindhoven 2016== | ==iGEM TU Eindhoven 2016== | ||
===Applications of BBa_K2065003=== | ===Applications of BBa_K2065003=== | ||
| − | iGEM TU Eindhoven planned to use CT52-Caspase 9 on testing the effectivity of a homotetrameric T14-3-3 scaffold protein. Another use of CT52-Caspase 9 in our project was testing whether a T14-3-3 mediated kill switch could viable. | + | iGEM TU Eindhoven planned to use CT52-Caspase 9 on testing the effectivity of a homotetrameric T14-3-3 scaffold protein. Another use of CT52-Caspase 9 in our project was testing whether a T14-3-3 mediated kill switch could viable. In figure 1 a schematic representation of an measurement using CT52-Caspase 9 is depicted which could provide these results. |
| + | |||
| + | [[File:T--TU-Eindhoven--Casp9As.png]] | ||
| + | |||
| + | <br> | ||
| + | ''Figure 1: the tetrameric scaffold increasing local concentrations of Caspase-9 better than a dimer, inducing the apoptosis pathway more efficiently.'' | ||
===User Reviews=== | ===User Reviews=== | ||
Latest revision as of 00:37, 19 October 2016
iGEM TU Eindhoven 2016
Applications of BBa_K2065003
iGEM TU Eindhoven planned to use CT52-Caspase 9 on testing the effectivity of a homotetrameric T14-3-3 scaffold protein. Another use of CT52-Caspase 9 in our project was testing whether a T14-3-3 mediated kill switch could viable. In figure 1 a schematic representation of an measurement using CT52-Caspase 9 is depicted which could provide these results.
Figure 1: the tetrameric scaffold increasing local concentrations of Caspase-9 better than a dimer, inducing the apoptosis pathway more efficiently.
User Reviews
UNIQa59d70e8db05dcab-partinfo-00000000-QINU UNIQa59d70e8db05dcab-partinfo-00000001-QINU